The Centers for Medicare and Medicaid Services announced this week a finalized rule prohibiting the use of federal Medicaid and Children’s Health Insurance Program dollars to fund gender-affirming medications and surgeries for minors. The rule restricts coverage for anyone under 18 through Medicaid and anyone under 19 through CHIP, though mental health care remains federally fundable and states retain the option to use their own dollars for such treatment.
The rule is scheduled to take effect on October 13, following a regulatory process in which the agency received nearly 35,000 public comments. Legal experts characterize the CMS approach as more procedurally grounded than previous administration initiatives in this area, suggesting the agency has attempted to strengthen its legal positioning by following standard regulatory channels. Health policy analysts note the rule includes an explicit tapering period allowing federal funds to continue covering hormones for six months after implementation, until April 2027.
Legal challenges are anticipated, with Massachusetts’s attorney general confirming plans to contest the rule in court. Experts acknowledge uncertainties surrounding the rule’s durability, including questions about whether the scientific evidence cited adequately supports the coverage restriction and whether the agency is overstepping into territory traditionally regulated by states. The CMS asserts it possesses independent legal authority to determine federal Medicaid coverage, though lawyers note the agency’s unilateral decision to revoke coverage without congressional direction may be unprecedented.
According to KFF estimates, approximately 130,000 young transgender people covered by Medicaid or CHIP reside in states where gender-affirming care remains legal. Policy analysts note that while states could theoretically offset lost federal funding, doing so may prove challenging given concurrent coverage changes expected to affect millions of individuals. The rule represents one of two related proposals, with a second, more restrictive rule targeting hospital participation in Medicaid also under consideration.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI